Effect of smoking on neuroleptics in schizophrenia

Schizophrenia Research

Volumn 23, Issue 1, 1997, Pages 55-60

  Salokangas, Raimo K R ^a   Saarijärvi, Simo ^a   Taiminen, Tero ^a   Lehto, Heikki ^b   Niemi, Heikki ^b   Ahola, Virpi ^c   Syvälahti, Erkka ^c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b H LUNDBECK A S   (Denmark)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

age; neuroleptics; oestrogens; schizophrenia; sex; smoking

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING;

ADULT; AGE FACTORS; AGED; ANTIPSYCHOTIC AGENTS; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; SMOKING;

EID: 0031575405     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(96)00083-7     Document Type: Article

References (33)

1. Bech, P., Malt, U.F., Dencker, S.J., Ahlfors, U.G., Elgen, K., Lewander, T., Lundell, A., Simpson, G.M. and Lingjaerde, O. (1993) Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr. Scand. 87 (Suppl. 372), 30-31.
2. Carr, L.A., Rowell, P.P. and Pierce, W.M. (1989) Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat. Neurochem. Res. 515, 511-515.
3. Clarke, P. B. and Perr, A. (1985) Autoradiographic evidence for nicotine receptors on nigro-striatal and mesolimbic dopaminergic neurons. Brain Res. 348, 355-358.
4. de Leon, J., Dadvand, M., Canuso, C., White, A.O., Stanilla, J.K. and Simpson, G.M. (1995) Schizophrenia and smoking: an epidemiologic survey in a state hospital. Am. J. Psychiatry, 152, 453-455.
5. Di Paolo, T., Poyet, P. and Labrie, F. (1981) Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur. J. Pharmacol. 73, 105-106.
6. Dworkin, R.J. and Adams, G.L. (1984) Pharmacotherapy of the chronic patient: gender and diagnostic factors. Community Ment. Health J. 20, 253-261.
7. Ereshefsky, L., Saklad, S.R., Watanabe, M.D. et al. (1991) Thiotixene pharmacokinetic interactions: a study of hepatic enzyme inducers, clearance inhibitors, and demographic variables. J. Clin. Psychopharmacol. 11, 292-300.
8. Glassman, A.H. (1993) Cigarette smoking: implications for psychiatric illness. Am. J. Psychiatry 150, 546-553.
9. Goff, D.C., Henderson, D.C. and Amica, B.S. (1992) Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am. J. Psychiatry 149, 1189-1194.
10. Gordon, J.H., Borison, R.L. and Diamond, B.I. (1980) Modulation of dopamine receptor sensitivity by estrogen. Biol. Psychiatry 389-396.
11. Häfner, H., Riecher, A., Mauer, K., Löffler, W., Munk-Jörgensen, P. and Strömgren, E. (1989) How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol. Med. 19, 903-918.
12. Häfner, H., Behrens, S., De-Vry, J. and Gattaz, W.F. (1991) Oestradiol enhances the vulnerability threshold for schizophrenia in women by early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments. Eur. Arch. Psychiatry Clin. Neurosci. 241, 65-68.
13. Haring, C., Meise, U., Humpel, C., Saria, A., Fleischhacker, W.W. and Hinterhuber, H. (1989) Dose-related plasma levels of clozapine: influence of smoking behavior, sex, and age. Psychopharmacology 99, S38-S40.
14. Hughes, J.R. (1993) Possible effects of smoker-free inpatient units on psychiatric diagnosis and treatment. J. Clin. Psychiatry 54, 109-114.
15. Hughes, J.R., Hatsukami, D.K., Mitchell, J.E. and Dahlgren, L. A. (1986) Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry 143, 993-997.
16. Jann, M., Saklad, S.R., Ereshefsky, L., Richards, A.L., Harington, C.A. and Davis, C.M. (1986) Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance. Psychopharmacology 90, 468-470.
17. Jarvik, M.E. and Schneider, N.G. (1992) Nicotine. In: Lowinson, J.H., Ruiz, P. and Millman, R.B. (Eds.). Substance Abuse: A Comprehensive Textbook, 2nd Edn. Williams and Wilkins, Baltimore, MD.
18. Kay, S.R., Opler, L.A. and Fiszbein, A. (1987) Positive and negative syndrome scale (PANSS) rating manual. Social and Behavioral Sciences Documents, San Rafael.
19. Lohr, J.B. and Flynn, K. (1992) Smoking and schizophrenia. Schizophrenia Res. 8, 93-102.
20. Miller, R.R. (1977) Effects of smoking on drug action. Clin. Pharmacol. Ther. 22, 749-756.
21. Morgan, M.Y. and Sherlock, S. (1977) Sex-related differences among 100 patients with alcoholic liver disease. Br. Med. J. i, 939-941.
22. 11C)-raclopride. J. Cereb. Blood Flow Metab. 13, 310-314.
23. Salokangas, R.K.R. (1995) Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis. Schizophr. Res. 16, 7-16.
24. Salokangas, R.K.R., Saarijärvi, S., Taiminen, T., Kallioniemi, H., Lehto, H., Niemi, H., Tuominen, J., Ahola, V. and Syvälahti, E. (1996) Citalopram as an adjuvant in chronic schizophrenia: a double-blind placebo-controlled study. Acta Psychiatr. Scand. 94, 175-180.
25. SAS Institute Inc., (1994) version 6.08, Gary, NC, USA.
26. Seeraan, M.V. (1983) Interaction of sex, age, and neuroleptic dose. Comp. Psychiatry 24, 125-128.
27. Seeman, M.V. (1986) Current outcome in schizophrenia: women vs men. Acta Psychiatr. Scand. 73, 609-617.
28. Seeman, P. (1985) Brain dopamine receptors in schizophrenia. In: Menuck, M.N. and Seeman, M.V. (Eds.). New Perspectives in Schizophrenia. Macmillan, New York, NY, pp. 71-79.
29. Seeman, M.V. and Lang, M. (1990) The role of estrogens in schizophrenia gender differences. Schizophr. Bull. 16, 185-194.
30. Vestal, R.E., Montamat, S.C. and Nielson, C.P. (1992) Drugs in special groups: The eiderly. In: Melmon, K.L., Morrelli, H.F., Hoffman, B.B. and Nierenberg, D.W. (Eds.). Melmon and Morrelli's Clinical Pharmacology. Basic Principles and Therapeutics, 3rd edn. McGraw-Hill, New York, NY, pp. 851-874.
31. Wong, D.F., Wagner, H.N. Jr, Dannals, R.E., Links, J.M., Frost, J.J., Ravert, H.T., Wilson, A.A., Rosenbaum, A.E., Gjedde, A., Douglas, K.H., Petronis, J.D., Folstein, M.F., Toung, J.K.T., Burns, H.D. and Kuhar, M.J. (1984) Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living human brain. Science 226, 1393-1396.
32. Wyatt, R.J. (1976) Biochemistry and Schizophrenia (Part IV). The neuroleptics-their mechanism of action: a review of the biochemical literature. Psychopharmacol. Bull. 12, 5-55.
33. Ziedonis, D.M., Kosten, T.R., Glazer, W.M. and Frances, R.J. (1994) Nicotine dependence and schizophrenia. Hosp. Commun. Psychiatry 45, 204-206.